Healix Infusion Therapy, Inc. v. Helix Health, LLC

737 F. Supp. 2d 648, 2010 U.S. Dist. LEXIS 82030, 2010 WL 3218881
CourtDistrict Court, S.D. Texas
DecidedAugust 12, 2010
DocketCivil Action H-09-2072
StatusPublished
Cited by3 cases

This text of 737 F. Supp. 2d 648 (Healix Infusion Therapy, Inc. v. Helix Health, LLC) is published on Counsel Stack Legal Research, covering District Court, S.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Healix Infusion Therapy, Inc. v. Helix Health, LLC, 737 F. Supp. 2d 648, 2010 U.S. Dist. LEXIS 82030, 2010 WL 3218881 (S.D. Tex. 2010).

Opinion

MEMORANDUM AND ORDER

NANCY F. ATLAS, District Judge.

This case comes before the Court on the First Amended Motion for Summary Judgment [Doc. # 49] (“Plaintiffs Motion”) 1 filed by Plaintiff and Counter Defendant Healix Infusion Therapy, Inc. (“HIT” or “Plaintiff’) and the Motion for Partial Summary Judgment [Doc. # 51] (“Defen *652 dants’ Motion”) 2 filed by Defendants and Counter Plaintiffs Helix Health, LLC and Steven Murphy (“Defendants”). After carefully considering the parties’ submissions, applicable legal authorities, and all pertinent matters of record, the Court denies Plaintiffs Motion and grants in part and denies in part Defendants’ Motion.

1. FACTUAL BACKGROUND

This case arises from a previous lawsuit filed by Plaintiff against Defendants. Plaintiff Healix Infusion Therapy, is a provider of “drug compounding, infusion therapy and practice management services to physicians.” 3 HIT, which is based in Sugar Land, Texas, asserts that it is the owner of several federally registered trademarks including, “HEALIX” and “Healix Health Services.” Defendant Steven Murphy is a Connecticut physician and owner of Helix Health LLC, now known as The Personalized Medicine Group of Connecticut, LLC (“Helix Health”).

In January 2008, HIT filed suit against Helix Health and Murphy. See Healix Infusion Therapy, Inc. v. Helix Health, LLC, et al., Civil Action No, 4:08-0337 (S.D. Tex. filed January 30, 2008) (“Underlying Litigation”). HIT raised claims for trademark infringement and dilution, as well as fraud and cybersquatting. With the exception of the cybersquatting claim, the court, Judge Lake presiding, dismissed HIT’s claims for lack of personal jurisdiction. 4 Judge Lake subsequently granted summary judgment in Murphy’s favor on the cybersquatting claim 5 and entered a final judgment dismissing HIT’s claims with prejudice and taxing costs against HIT. 6

HIT appealed the judgment. While the appeal was pending, on May 1, 2009, the parties entered into a Settlement Agreement. 7 As part of the Settlement Agreement, HIT agreed to pay $7,500 to Helix Health and Murphy, withdrew its appeal, and agreed to not bring further suit against the two defendants for trademark infringement. In exchange, Helix Health and Murphy agreed to abandon a pending trademark application for “Helix Health” and to cease within 30 days all use of “Helix Health,” Helix,” and any “derivative thereof’ except that Murphy would be permitted to use the following identifiers: “(1) Helix Health of Connecticut,” “(2) Helix Health of Delaware, and (3) Helix Health of New York.” 8 This “Cessation of Use” clause of the Settlement Agreement further provided that Helix Health and Murphy would have “six months to change the corporate name of Helix Health LLC to allow for notice and transition of name changes and payments by third party payors.” 9 The Settlement Agreement also provided for the transfer of certain Internet domain names from Helix Health and Murphy to HIT and for the rerouting of associated emails to Murphy’s new email address. 10

*653 Approximately two months after the parties entered into the Settlement Agreement, Plaintiff filed this suit alleging that Defendants have continued to use the identifier “Helix” in violation of the Cessation of Use clause. Plaintiff asserts claims for breach of the Settlement Agreement and for trademark infringement under the Lanham Act, 15 U.S.C. § § 1114, 1125. Defendants, alleging that Plaintiff intercepted emails intended for Murphy following the domain transfer, bring counterclaims for breach of the Settlement Agreement, invasion of privacy, violations of the Federal Wiretap Act, 18 U.S.C. § 2520, and violations of the Federal Stored Communications Act, 18 U.S.C. § 2707. 11

The parties have cross moved for summary judgment on the breach of contract claim. Plaintiff has also moved for summary judgment on the trademark infringement claim and all of Defendants’ counterclaims. Defendants additionally seek summary judgment on five other discreet issues addressed below.

II. SUMMARY JUDGMENT STANDARD

Rule 56 of the Federal Rules of Civil Procedure mandates the entry of summary judgment, after adequate time for discovery and upon motion, against a party who fails to make a sufficient showing of the existence of an element essential to the party’s case, and on which that party will bear the burden at trial. Celotex Corp. v. Catrett, 477 U.S. 317, 322, 106 S.Ct. 2548, 91 L.Ed.2d 265 (1986); Little v. Liquid Air Corp., 37 F.3d 1069, 1075 (5th Cir. 1994) (en banc); see also Baton Rouge Oil and Chem. Workers Union v. ExxonMobil Corp., 289 F.3d 373, 375 (5th Cir.2002). Summary judgment “should be rendered if the pleadings, the discovery and disclosure materials on file, and any affidavits show that there is no genuine issue as to any material fact and that the movant is entitled to judgment as a matter of law.” Fed. R. Civ. P. 56(c); Celotex, 477 U.S. at 322-23, 106 S.Ct. 2548; Weaver v. CCA Indus., Inc., 529 F.3d 335, 339 (5th Cir.2008).

For summary judgment, the initial burden falls on the movant to identify areas essential to the non-movant’s claim in which there is an “absence of a genuine issue of material fact.” Lincoln Gen. Ins. Co. v. Reyna, 401 F.3d 347, 349 (5th Cir. 2005). The moving party, however, need not negate the elements of the non-movant’s case. See Boudreaux v. Swift Transp. Co., 402 F.3d 536, 540 (5th Cir.2005).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Allamon v. Acuity Specialty Products, Inc.
877 F. Supp. 2d 498 (E.D. Texas, 2012)
Healix Infusion Therapy, Inc. v. Helix Health, LLC
747 F. Supp. 2d 730 (S.D. Texas, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
737 F. Supp. 2d 648, 2010 U.S. Dist. LEXIS 82030, 2010 WL 3218881, Counsel Stack Legal Research, https://law.counselstack.com/opinion/healix-infusion-therapy-inc-v-helix-health-llc-txsd-2010.